Sanofi teams up with Google Life Sciences to improve diabetes health outcomes

Sanofi and the life sciences team at Google announced that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes

Sanofi teams up with Google Life Sciences to improve diabetes health outcomes

Sanofi and Google

Ratio: 0 / 5

Inicio desactivadoInicio desactivadoInicio desactivadoInicio desactivadoInicio desactivado
 

The aim is to use data and miniaturized technology to provide patients with more tools to self-manage their disease, healthcare professionals with the ability to better support and treat patients 

Sanofi and the life sciences team at Google announced that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes. The collaboration will pair Sanofi's leadership in diabetes treatments and devices with Google's expertise in analytics, miniaturized electronics and low power chip design.

The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.

Sanofi and the life sciences team at Google will combine their respective expertise in science and technology to work on better ways to collect, analyze and understand multiple sources of information impacting diabetes. The hope is that it will be easier for patients to successfully manage their diabetes, which would reduce the risk of complications, improve outcomes and ultimately lower costs.

"As a global leader in diabetes care, we have both an obligation and a commitment to provide integrated solutions for people living with diabetes," said Olivier Brandicourt, MD, Chief Executive Officer, Sanofi. "This initiative combines Sanofi's strength and knowledge in diabetes with Google's leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care."

"With new technologies emerging to provide a more continuous and real-time view of a patient's health, we can see the promise for more proactive and effective ways to control diabetes," said Andy Conrad, CEO of the life sciences team at Google. "Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life."